Literature DB >> 8636073

The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1.

A Graziani1, F Galimi, E Medico, E Cottone, D Gramaglia, C Boccaccio, P M Comoglio.   

Abstract

nef is a human immunodeficiency virus (HIV) gene encoding a 27-kDa myristoylated protein with structural features of a signal transducing molecule, but whose functions are largely unknown. We studied the interactions of Nef with the signal transduction pathways triggered by the platelet-derived growth factor (PDGF) receptor. The association of phosphatidylinositol (PI) 3-kinase with the activated receptor was severely impaired by nef expression. Conversely, PDGF-induced receptor tyrosine phosphorylation, binding to phospholipase C-gamma and to Ras-GAP were not modified. Microtubule-associated protein kinase activation and intracellular calcium influx in response to PDGF were either unaffected or only slightly enhanced. Nef significantly reduced the proliferative response to the growth factor, while the chemotactic response was unchanged. These data show that Nef affects selectively the PI 3-kinase signaling pathway and suggest that this interference results in some of the HIV adverse effects on host cell functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636073     DOI: 10.1074/jbc.271.12.6590

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation.

Authors:  L Alexander; Z Du; M Rosenzweig; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo.

Authors:  Mamoru Matsubara; Tao Jing; Kumi Kawamura; Naoshi Shimojo; Koiti Titani; Keiichiro Hashimoto; Nobuhiro Hayashi
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

Review 3.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

4.  HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.

Authors:  John C Marecki; Carlyne D Cool; Jane E Parr; Virginia E Beckey; Paul A Luciw; Alice F Tarantal; Angela Carville; Richard P Shannon; Adela Cota-Gomez; Rubin M Tuder; Norbert F Voelkel; Sonia C Flores
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

5.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

6.  Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling.

Authors:  A J Iafrate; S Bronson; J Skowronski
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

7.  Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus.

Authors:  W Luo; B M Peterlin
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.

Authors:  Otto O Yang; Phuong Thi Nguyen; Spyros A Kalams; Tanya Dorfman; Heinrich G Göttlinger; Sheila Stewart; Irvin S Y Chen; Steven Threlkeld; Bruce D Walker
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Constitutive activation of phosphatidylinositol 3-kinase signaling pathway down-regulates TLR4-mediated tumor necrosis factor-alpha release in alveolar macrophages from asymptomatic HIV-positive persons in vitro.

Authors:  Souvenir D Tachado; Xin Li; Katharine Swan; Naimish Patel; Henry Koziel
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

Review 10.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.